Sign inGet started

Khan Samina

Insider CIK 1903865 · RETA SVP, Chief Medical Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
RETA REATA PHARMACEUTICALS INC S Sale2023-05-162023-05-17352$81.37 $28.6K39,491SEC↗
RETA REATA PHARMACEUTICALS INC S Sale2023-05-152023-05-17288$85.32 $24.6K39,843SEC↗
RETA REATA PHARMACEUTICALS INC S Sale2023-03-072023-03-083,961$83.46 $330.6K40,131SEC↗
RETA REATA PHARMACEUTICALS INC S Sale2023-03-032023-03-062,813$87.36 $245.7K44,092SEC↗
RETA REATA PHARMACEUTICALS INC M Exercise deriv2023-03-022023-03-0625,000— $025,000SEC↗
RETA REATA PHARMACEUTICALS INC S Sale2023-03-022023-03-063,395$83.70 $284.2K68,510SEC↗
RETA REATA PHARMACEUTICALS INC S Sale2023-03-022023-03-0618,956$85.02 $1.61M49,554SEC↗
RETA REATA PHARMACEUTICALS INC S Sale2023-03-022023-03-062,649$85.38 $226.2K46,905SEC↗
RETA REATA PHARMACEUTICALS INC M Exercise2023-03-022023-03-0625,000$27.32 $683.0K71,905SEC↗
RETA REATA PHARMACEUTICALS INC A Award deriv2023-01-032023-01-0447,738— $047,738SEC↗
RETA REATA PHARMACEUTICALS INC A Award2023-01-032023-01-0411,756— $046,905SEC↗